|
|
HIV Update 2002 (2) - FebruaryPublished by: Datamonitor Published: Apr. 16, 2002 - 36 Pages Table of ContentsEXECUTIVE SUMMARY Key Market Events in February 2002 STRUCTURE OF UPDATE ANALYSIS OF KEY DEVELOPMENTS IN FEBRUARY 2002 COMPANY HEADLINES Ciphergen Partners with the NIAID to Halt HIV Replication GSK Urged to Reduce Prices of Anti-HIV Drugs Merck’s HIV research program enters Phase I Clinical Trials Achillion To Use ViroLogic Assays for Lead Agent Evaluation Berna Enter Partnership with IAVI for AIDS Vaccine Tests Approval for BMS’s Sustiva as a One Tablet, Once Daily Formulation RESEARCH AND DEVELOPMENT HEADLINES Viread Shows Promise in Treating HIV/HBV Co-infected Individuals Nasal HIV Vaccine Could Offer Effective Protection AnorMED Presents New Clinical Data at Seattle Low Dose Ritonavir Effective at Reducing Viral load in Combination with Amprenavir Low Dosage Pipeline Anti-Cancer Drug Effective Against HIV-Infected Cells Roche’s T-20 Exhibits Potent Antiviral Activity in Treatment-Experienced Patients Recombinant Human Growth Hormone Improves Lipid Profile in HIV-Infected Patients with Lipodystrophy Drug Switching Due to Side Effects Does Not Affect Viral Load DISEASE SPECIFIC HEADLINES US HIV Sufferers Taking Treatment Delays To An Extreme Acute Hepatitis A Viremia Prolonged in HIV-Coinfected Patients Febrile Seizures Linked to Maternal HIV Therapy HIV Levels Increased 200-Fold with Cocaine Use HIV-Positive Couples Should Not Be Discouraged to Have Children Women are Fastest Growing Population in US HIV Epidemic Vaginal Transmission of Cell-Associated HIV Blocked In Vitro HAART Improves HIV-Associated Anemia EMERGING MARKETS HEADLINES VaxGen to Build Vaccine Manufacturing Facilities in South Korea Access to Viramune Dependent Upon Outcome of Research Says South African Government Blood Supply Vital To Stemming Emerging Market HIV Spread Russia’s AIDS Crisis Could Overshadow Africa’s Pledge to Intensify Efforts at Combating AIDS in South Africa Spread of HIV in Asian Intravenous Drug Users Via Increased Drug Trafficking Routes New Investment in Developing World HIV/AIDS Treatment Following World Economic Forum APPENDIX Datamonitor's Infectious Disease Business Unit Research Background Contacts and Further Reading © Datamonitor 2002. All Rights Reserved. AbstractThis HIV monthly update provides a detailed analysis of all the clinical and commerical events that occurred within the HIV and Aids market in February 2002. The update is divided into four sections covering Company Specific, Research and Development, Disease Specific and Emerging Markets events, and is sourced from a wide range of journals, supported through conference participation and ongoing Opinion Leader primary research.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||